SA PRO
Free Account
Themes
Viatris Inc.VTRSNASDAQ
Loading
OverviewIntelligenceChartsNews

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
12 analysts·Moderate coverage
17%
Rating Distribution
Strong Buy
00%
Buy
217%
Hold
867%
Sell
217%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 9, 2026UBS
Viatris upgraded to Buy from Neutral at UBS
Target:$18.00
+23.5%from $14.58
Jan 28, 2026Piper Sandler
Viatris price target raised to $12 from $9 at Piper Sandler
Target:$12.00
-8.5%from $13.12
Jan 16, 2026Argus Research
Argus upgrades Viatris to Buy on expected buybacks, debt reduction
Target:$15.00
+16.8%from $12.84
Jan 7, 2026Truist Financial
Viatris price target raised to $16 from $15 at Truist
Target:$16.00
+29.0%from $12.40
Oct 15, 2025Truist Financial
Viatris initiated with a Buy at Truist
Target:$15.00
+51.1%from $9.93
Jul 19, 2024Jefferies
Viatris reinstated with a Buy at Jefferies
Target:$15.00
+27.4%from $11.77
Mar 28, 2024Piper Sandler
Viatris (VTRS) PT Raised to $13 at Piper Sandler on latest Idorsia deals
Target:$13.00
+9.9%from $11.83
Jun 26, 2023Piper Sandler
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
Target:$10.00
+1.7%from $9.84
Feb 1, 2023Barclays
Barclays Maintains Overweight on Viatris, Lowers Price Target to $15
Target:$15.00
+23.4%from $12.16
Nov 9, 2022UBS
UBS Upgrades Viatris (VTRS) to Neutral
Target:$12.00
+10.8%from $10.83
Jun 13, 2022UBS
Viatris initiated with a Sell at UBS
Target:$9.00
-16.4%from $10.77

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance